Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-01-04 @ 10:57 PM
Study NCT ID:
NCT04665856
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-29
First Post:
2020-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-07
First Submit QC Date:
None
Study First Post Date:
2020-12-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-26
Results First Submit QC Date:
None
Results First Post Date:
2025-10-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-10-29
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2025-10-15
Last Update Post Date:
2025-10-29
Last Update Post Date Type:
ESTIMATED